La catena delle opzioni mostra i dati chiave delle opzioni azionarie di MGP Ingredients a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per MGP Ingredients..

MGP Ingredients (NASDAQ:MGPI) Azioni, Catena delle Opzioni

MGP INGREDIENTS INC

MGP Ingredients

MGP Ingredients Inc is a producer and supplier of premium distilled spirits and specialty wheat protein and starch food ingredients. MGP also produces high-quality industrial alcohol for use in both food and non-food applications. It operates in three segments: Distillery Solutions, Branded Spirits Segment, and Ingredient Solutions. Distillery Solutions provides distillery co-products, such as distillers feed, fuel grade alcohol, and corn oil: and warehouse services, including barrel put away, storage, and retrieval services. It derives its revenue from the Distillery Solutions segment.

MGP Ingredients Inc

WIIM

ABEV

ANDE

BRBR

BRFS

CART

CASY

CELH

CENT

CENTA

COCO

COKE

COST

COTY

FIZZ

Fomento Economico Mexicano S.A.B. De C.V.

FRPT

HFFG

HNST

IPAR

ISPR

MDLZ

MGPI

MNST

PFGC

PSMT

SNYR

TBBB

UNFI

UPXI

USFD

USNA

WALD

WEST

Shares of consumer staple companies are trading higher following President Trump's decision to implement a 90-day pause on reciprocal tariffs for all countries except China.

Wells Fargo analyst Marc Torrente maintains MGP Ingredients (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MGPI#NASDAQ">MGPI</a>) with a Overweight and lowers the price target from $40 to $37.

News

Price Target

Analyst Ratings

Wells Fargo Maintains Overweight on MGP Ingredients, Lowers Price Target to $37

Lake Street analyst Ben Klieve upgrades MGP Ingredients (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MGPI#NASDAQ">MGPI</a>) from Hold to Buy and lowers the price target from $55 to $45.

Upgrades

Lake Street Upgrades MGP Ingredients to Buy, Lowers Price Target to $45

MGP Ingredients Sees FY25 Net Sales Between $520M-$540M Vs. $593.01M Estimate

MGP Ingredients (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MGPI#NASDAQ">MGPI</a>) reported quarterly earnings of $1.64 per share which beat the analyst consensus estimate of $1.50 by 9.33 percent. This is unchanged from the same period last year. The company reported quarterly sales of $180.80 million which beat the analyst consensus estimate of $177.17 million by 2.05 percent. This is a 15.87 percent decrease over sales of $214.89 million the same period last year.

Earnings

Earnings Beats

MGP Ingredients Q4 Adj EPS  $1.64 Beats $1.50 Estimate, Sales $180.80M Beat $177.17M Estimate

AAOI

ACAD

ACMR

ADTN

ALEC

AMBA

AMBC

AMSF

ARDT

ARHS

ARIS

ARKO

ASTE

ATEC

AVDX

AVNS

BATRA

BATRK

BBSI

BLMN

BXSL

BYND

CAPL

CDNA

CERT

CLDT

CLPT

COMM

CORT

Core Scientific, Inc. - Class A Common Stock

CORZ

CPRX

CRGY

CSAN

CTRI

DHIL

DMRC

DOLE

DORM

EBAY

ECPG

EHTH

ENIC

ENOV

ERII

ESCA

ESTA

EVTC

FTAI

FWRD

GERN

GOGL

GSX Techedu Inc. American Depositary Shares

GOTU

GRBK

HCAT

IBTA

IMCR

Earnings Scheduled For February 26, 2025

BF/A

BF/B

WVVI

Shares of alcohol stocks are trading lower as investors assess U.S. tariff risks which may negatively impact the industry.

Wells Fargo analyst Marc Torrente maintains MGP Ingredients (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MGPI#NASDAQ">MGPI</a>) with a Overweight and lowers the price target from $58 to $44.

Wells Fargo Maintains Overweight on MGP Ingredients, Lowers Price Target to $44

Roth MKM analyst Sean McGowan maintains MGP Ingredients (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MGPI#NASDAQ">MGPI</a>) with a Buy and lowers the price target from $65 to $60.

Roth MKM Maintains Buy on MGP Ingredients, Lowers Price Target to $60

TD Cowen analyst Robert Moskow downgrades MGP Ingredients (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MGPI#NASDAQ">MGPI</a>) from Buy to Hold and lowers the price target from $66 to $50.

Downgrades

TD Cowen Downgrades MGP Ingredients to Hold, Lowers Price Target to $50

Roth MKM analyst Sean McGowan maintains MGP Ingredients (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MGPI#NASDAQ">MGPI</a>) with a Buy and lowers the price target from $69 to $65.

Roth MKM Maintains Buy on MGP Ingredients, Lowers Price Target to $65

Truist Securities analyst Bill Chappell maintains MGP Ingredients (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MGPI#NASDAQ">MGPI</a>) with a Buy and lowers the price target from $85 to $75.

Truist Securities Maintains Buy on MGP Ingredients, Lowers Price Target to $75

MGP Ingredients shares are trading lower after the company reported mixed Q3 financial results and cut its FY24 guidance.

Guidance

MGP Ingredients Lowers FY24 Outlook: Sees Sales Of $695M-$705M Vs. $699.26M Estimate (Prior View: $742M-$756M); Projects Adjusted EPS Of  $5.55-$5.65 Vs. $5.57 Estimate (Prior View: $6.12-$6.23)

MGP Ingredients (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MGPI#NASDAQ">MGPI</a>) reported quarterly earnings of $1.29 per share which beat the analyst consensus estimate of $1.25 by 3.2 percent. The company reported quarterly sales of $161.461 million which missed the analyst consensus estimate of $161.551 million by 0.06 percent. This is a 23.70 percent decrease over sales of $211.624 million the same period last year.

Earnings Misses

MGP Ingredients Q3 2024 Adj. EPS $1.29 Beats $1.25 Estimate, Sales $161.461M Miss $161.551M Estimate

Truist Securities analyst Bill Chappell maintains MGP Ingredients (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MGPI#NASDAQ">MGPI</a>) with a Buy and lowers the price target from $95 to $85.

Truist Securities Maintains Buy on MGP Ingredients, Lowers Price Target to $85

U.S. stocks traded mostly higher toward the end of trading, with the Nasdaq Composite gaining over 100 points on Friday.
The Dow traded up 0.04% to 43,258.31 while the NASDAQ rose 0.67% to 18,496.61. The S&amp;P 500 also rose, gaining, 0.40% to 5,865.01.
Check This Out: <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/10/41377157/top-3-risk-off-stocks-which-could-rescue-your-portfolio-this-quarter">Top 3 Risk Off Stocks Which Could Rescue Your Portfolio This Quarter</a>
Leading and Lagging Sectors Communication services shares jumped by 1% on Friday.
In trading on Friday, energy shares fell by 0.5%.
Top Headline
Schlumberger N.V. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SLB#NYSE">SLB</a>) reported mixed third-quarter results.
Revenue grew 10.2% year over year to $9.159 billion, missing the consensus of $9.25 billion. Adjusted EPS increased 14% to 89 cents, above the consensus of 88 cents.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>United States Cellular Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/USM#NYSE">USM</a>) shares shot up 7% to $62.56 after the company announced the sale of a portion of its retained spectrum licenses to Verizon for $1 billion.</li>
<li>Shares of Bright Minds Biosciences Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DRUG#NASDAQ">DRUG</a>) got a boost, surging 159% to $56.25. The company announced a $35 million non-brokered private placement.</li>
<li>SOBR Safe, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOBR#NASDAQ">SOBR</a>) shares were also up, gaining 27% to $10.10 after the company announced it filed a form RW and will not pursue a public offering at this time.</li>
</ul>
Equities Trading DOWN
<ul>
<li>MGP Ingredients, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MGPI#NASDAQ">MGPI</a>) shares dropped 25% to $60.96 after the company issued soft preliminary guidance and lowered its 2024 financial outlook.</li>
<li>Shares of Lilium N.V. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LILM#NASDAQ">LILM</a>) were down 15% to $0.4917. On Thursday, Canaccord Genuity downgraded the stock from Buy to Hold and cut its price target from $1.85 to $0.70.</li>
<li>CVS Health Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVS#NYSE">CVS</a>) was down, falling 6% to $59.83 after the company cut its third-quarter outlook.</li>
</ul>
Commodities In commodity news, oil traded down 1.5% to $69.62 while gold traded up 0.9% at $2,731.20.
Silver traded up 4.9% to $33.325 on Friday, while copper rose 1.5% to $4.3880.
Euro zone
European shares closed mostly higher today. The eurozone's STOXX 600 rose 0.21%, Germany's DAX rose 0.38% and France's CAC 40 climbed 0.39%. Spain's IBEX 35 Index rose 0.17%, while London's FTSE 100 fell 0.32%.
Construction output in the Eurozone fell by 2.5% year-over-year in August compared to a revised 2.3% decline in the previous month. The current account surplus in the Eurozone increased to €35.2 billion in August from €26.8 billion in the year-ago period.
Asia Pacific Markets
Asian markets closed higher on Friday, with Japan's Nikkei 225 gaining 0.18%, Hong Kong's Hang Seng Index climbing 3.61%, China's Shanghai Composite Index gaining 2.91% and India's BSE Sensex gaining 0.27%.
Economics
<ul>
<li>U.S. housing starts fell by 0.5% from the previous month to an annualized rate of 1.354 million units in September.</li>
<li>Building permits declined by 2.9% to an annual rate of 1.428 million in September.</li>
<li>The total number of active U.S. oil rigs rose by one to 482 rigs this week, Baker Hughes Inc reported.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/10/41402086/wall-streets-most-accurate-analysts-give-their-take-on-3-financials-stocks-delivering-hi">Wall Street&#8217;s Most Accurate Analysts Give Their Take On 3 Financials Stocks Delivering High-Dividend Yields</a></li>
</ul>

DRUG

LILM

SOBR

Nasdaq Surges Over 100 Points; Schlumberger Reports Mixed Q3 Result

U.S. stocks traded mostly higher midway through trading, with the Nasdaq Composite gaining around 100 points on Friday.
The Dow traded up 0.03% to 43,252.87 while the NASDAQ rose 0.55% to 18,474.05. The S&amp;P 500 also rose, gaining, 0.33% to 5,861.03.
Check This Out: <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/10/41377157/top-3-risk-off-stocks-which-could-rescue-your-portfolio-this-quarter">Top 3 Risk Off Stocks Which Could Rescue Your Portfolio This Quarter</a>
Leading and Lagging Sectors Communication services shares jumped by 1.2% on Friday.
In trading on Friday, energy shares fell by 1%.
Top Headline
American Express Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AXP#NYSE">AXP</a>) shares fell around 5% on Friday after the company reported results for the third quarter.
The company said quarterly revenue (net of interest expense) grew 8% year-on-year to $16.64 billion, marginally missing the analyst consensus estimate of $16.67 billion. Adjusted EPS of $3.49 beat the analyst consensus estimate of $3.28.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>United States Cellular Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/USM#NYSE">USM</a>) shares shot up 12% to $65.62 after the company announced the sale of a portion of its retained spectrum licenses to Verizon for $1 billion.</li>
<li>Shares of Bright Minds Biosciences Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DRUG#NASDAQ">DRUG</a>) got a boost, surging 196% to $64.35. The company announced a $35 million non-brokered private placement.</li>
<li>SOBR Safe, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOBR#NASDAQ">SOBR</a>) shares were also up, gaining 55% to $12.30 after the company announced it filed a form RW and will not pursue a public offering at this time.</li>
</ul>
<h3 class="wp-block-heading">Equities Trading DOWN</h3>
<ul>
<li>MGP Ingredients, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MGPI#NASDAQ">MGPI</a>) shares dropped 26% to $60.24 after the company issued soft preliminary guidance and lowered its 2024 financial outlook.</li>
<li>Shares of Lilium N.V. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LILM#NASDAQ">LILM</a>) were down 11% to $0.5101. On Thursday, Canaccord Genuity downgraded the stock from Buy to Hold and cut its price target from $1.85 to $0.70.</li>
<li>CVS Health Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVS#NYSE">CVS</a>) was down, falling 8% to $58.77 after the company cut its third-quarter outlook.</li>
</ul>
Commodities In commodity news, oil traded down 1.2% to $69.84 while gold traded up 0.9% at $2,731.90.
Silver traded up 2.9% to $32.705 on Friday, while copper rose 1.2% to $4.3785.
Euro zone
European shares were mixed today. The eurozone's STOXX 600 rose 0.1%, Germany's DAX rose 0.31% and France's CAC 40 climbed 0.35%. Spain's IBEX 35 Index fell 0.1%, while London's FTSE 100 fell 0.52%.
Construction output in the Eurozone fell by 2.5% year-over-year in August compared to a revised 2.3% decline in the previous month. The current account surplus in the Eurozone increased to €35.2 billion in August from €26.8 billion in the year-ago period.
Asia Pacific Markets
Asian markets closed higher on Friday, with Japan's Nikkei 225 gaining 0.18%, Hong Kong's Hang Seng Index climbing 3.61%, China's Shanghai Composite Index gaining 2.91% and India's BSE Sensex gaining 0.27%.
Economics
<ul>
<li>U.S. housing starts fell by 0.5% from the previous month to an annualized rate of 1.354 million units in September.</li>
<li>Building permits declined by 2.9% to an annual rate of 1.428 million in September.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/10/41402086/wall-streets-most-accurate-analysts-give-their-take-on-3-financials-stocks-delivering-hi">Wall Street&#8217;s Most Accurate Analysts Give Their Take On 3 Financials Stocks Delivering High-Dividend Yields</a></li>
</ul>

Equities

Eurozone

Commodities

Intraday Update

Markets

Trading Ideas

Crude Oil Down Over 1%; American Express Shares Fall After Q3 Results

Roth MKM analyst Sean McGowan maintains MGP Ingredients (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MGPI#NASDAQ">MGPI</a>) with a Buy and lowers the price target from $92 to $88.

Roth MKM Maintains Buy on MGP Ingredients, Lowers Price Target to $88

Lake Street analyst Ben Klieve downgrades MGP Ingredients (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MGPI#NASDAQ">MGPI</a>) from Buy to Hold and announces $75 price target.

Lake Street Downgrades MGP Ingredients to Hold, Announces $75 Price Target

Press Releases

Yellowstone Bourbon introduces new permanent addition to family of award-winning expressions with Small Batch 107

Blood Oath Pact 11 Kentucky Straight Bourbon Whiskey arrives at retail in April

Small Cap

MGPI Investors Have Opportunity to Lead MGP Ingredients, Inc. Securities Fraud Lawsuit with the Schall Law Firm

Legal

MGPI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that MGP Ingredients, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Comments

MGP Ingredients

MGP Ingredients (MGPI) Opzioni

MGP Ingredients (NASDAQ:MGPI) Azioni, Catena delle Opzioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO